Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Hautklinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Castor, T.; Wiechmann, N.; Besche, V. et al.

Differentiation of murine myeloid DC progenitors in the presence of glucocorticoid results in the induction of tolerogenic APCs

European Journal of Immunology. Bd. 39. H. 1. 2009 S. 649


Zuberbier, T; Asero, R; Bindslev-Jensen, C et al.

EAACI/GA superset of LEN/EDF/WAO guideline: management of urticaria

ALLERGY. Bd. 64. H. 10. 2009 S. 1427-1443


Zuberbier, T; Asero, R; Bindslev-Jensen, C et al.

EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

ALLERGY. Bd. 64. H. 10. 2009 S. 1417-1426


Raker, V.; Barwig, C.; Montermann, E. et al.

Effect of co-expressiion of TGF-ß1 after gene gun-mediates DNA immunization on transgene-specific immune responses

European Journal of Immunology. Bd. 39. H. 1. 2009 S. 549-549



Höhn, Y.; Thamsen, M.; Wiechmann, N. et al.

Eine nachhaltige Erhöhung des cAMP-Spiegels in murinen CD-Vorläuferzellen induziert einen protolerogenen DC-Status

Allergo Journal. Bd. 18. 2009 S. 36


Ngouateu, OB; von Stebut, E; Maurer, M et al.

Epidemiological investigations on cutaneous leishmaniasis and Leishmania/HIV co-infection in the Mokolo focus, Far North Province, Cameroon

EXPERIMENTAL DERMATOLOGY. Bd. 18. H. 3. 2009 S. 302-302


Besche, V; Wiechmann, N; Trojandt, S et al.

Genetically modified murine dendritic cells engineered to overexpress immunomodulatory cytokines display a protolerogenic status

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 379. 2009 S. 38-38


Frankenberg, UM; Lorenz, N; Grabbe, S et al.

Hapten-specific CD4+CD25+regulatory T cells are critical for low zone tolerance to contact allergens and induction of CD8+suppressor T cells

EXPERIMENTAL DERMATOLOGY. Bd. 18. H. 3. 2009 S. 275-275


Bork, K; Wulff, K; Hardt, J et al.

Hereditary angioedema caused by missense mutations in the factor XII gene: Clinical features, trigger factors, and therapy

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 124. H. 1. 2009 S. 129-134